Watch this video to learn more about Pfizer’s
process for manufacturing biosimilars.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

This video is intended to be viewed within the context of its original location online. Pfizer is not responsible for the content if viewed elsewhere. The information provided in this video is intended only for residents of the United States.

Pfizer standards
at work

State-of-the-art analytical tools help Pfizer Biosimilars development teams establish that the biosimilar products they develop match the reference products with a high degree of similarity.

  • This level of control and surveillance is essential because Pfizer is working with living cells to create very complex molecules
  • Because small changes in the raw materials used for the processing conditions, such as pressure and temperature environment, can affect the structure and function of the end product, precision is essential

Expansive footprint, sustainable supply

Pfizer Biosimilars is committed to high standards for quality, compliance, and supply reliability—fast, flexible solutions across the full manufacturing and supply‐chain spectrum.

manufacturing sites

As of May 2019.

Transitioning to value-based care? Learn How Biosimilars may help

You are now leaving Pfizer

Link to sites outside of Pfizer are provided as a resource to the viewer. Pfizer accepts no responsibility for the content of linked sites.